linagliptindpp4inhibitor

2016年7月21日—LinagliptinisaDPP-4inhibitorwithahighaffinityforDPP-4invarioustissues(15–17).Inrodents,linagliptinmoreeffectivelyreducesDPP ...,由PPToth著作·2011·被引用17次—LinagliptinisarecentlyapprovedDPP-4inhibitorwithuniquepharmacologicalproperties,includingveryhighaffinityfortheDPP-4enzyme,postdoseDPP-4 ...,2023年10月17日—UpToDate-Dipeptidylpeptidase4(DPP-4)inhibitorsforthetreatmentoftype2d...

參考資訊如下
DPP-4 Inhibition by Linagliptin Attenuates Obesity

2016年7月21日 — Linagliptin is a DPP-4 inhibitor with a high affinity for DPP-4 in various tissues (15–17). In rodents, linagliptin more effectively reduces DPP ...

Linagliptin: a new DPP

由 PP Toth 著作 · 2011 · 被引用 17 次 — Linagliptin is a recently approved DPP-4 inhibitor with unique pharmacological properties, including very high affinity for the DPP-4 enzyme, postdose DPP-4 ...

【衛教新訊】第二型糖尿病用藥-DPP

2023年10月17日 — UpToDate-Dipeptidyl peptidase 4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus; 中華民國藥師公會全國聯合會-短效與長效GLP-1R 致 ...

DPP

由 張琇涵 著作 · 2014 — DPP-4 inhibitor ； Linagliptin ； insulin signaling pathway ； neurodegeneration disorder ； Alzheimer disease. 參考文獻. Boerner, B. P., Miles, C. D. ...

DPP

DDP-4 inhibitors are a treatment to lower blood sugar levels in people with type 2 diabetes. They can be used on their own if metformin isn't suitable, or with ...

FDA warns that DPP

2015年8月28日 — The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin, ...

DPP

經查，我國核准DPP-4抑制劑類藥品許可證共30張，包含alogliptin、linagliptin、sitagliptin、saxagliptin、vildagliptin等5種成分；所有仿單已於「不良反應」或「副作用」 ...

DPP-4 inhibitors for treating T2DM

由 K Saini 著作 · 2023 · 被引用 22 次 — Sitagliptin, alogliptin and linagliptin possess high selectivity for DPP-4 due to strong binding with S2-extensive site which is absent in ...

DPP

This leaflet is designed for people taking a DPP-4 inhibitor, also known as a 'gliptin' for type 2 diabetes. What does this medication do?

說明